Imperial College London has "reached a significant milestone" after delivering a small dose of its coronavirus vaccine candidate to the first healthy volunteer in its trial. So far, all has gone according to plan. The clinical team is closely monitoring the participant's health, which remains in good condition, and there are no safety concerns.
Developing a vaccine for the COVID-19 virus is crucial during the pandemic, and it's worth keeping an eye on every effort. But Imperial College's candidate stands out because it's based on a new self-amplifying RNA technology, which has never before been involved in human trials. If it proves safe and effective, Imperial College believes it could revolutionize — and reduce the cost of — vaccine development, allowing scientists to take on emerging diseases like COVID-19 much more quickly in the future.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Anne Hillerman's 6 favorite books with Native charactersFeature The author recommends works by Ramona Emerson, Craig Johnson, and more
-
How Zohran Mamdani's NYC mayoral run will change the Democratic PartyTalking Points The candidate poses a challenge to the party's 'dinosaur wing'
-
Book reviews: '1861: The Lost Peace' and 'Murderland: Crime and Bloodlust in the Time of Serial Killers'Feature How America tried to avoid the Civil War and the link between lead pollution and serial killers
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measlesSpeed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study findsSpeed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influenceSpeed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
